Burning Rock Biotech Limited
BNR
$23.00
$0.251.10%
NASDAQ
| 09/30/2025 | 03/31/2025 | 12/31/2024 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.34M | -1.86M | -11.30M | -11.30M | -4.99M |
| Total Depreciation and Amortization | -- | -- | 7.14M | 7.14M | -- |
| Total Amortization of Deferred Charges | -- | -- | 113.00K | 113.00K | -- |
| Total Other Non-Cash Items | 4.63M | -1.38M | 11.77M | 11.77M | 763.70K |
| Change in Net Operating Assets | -- | -- | -5.08M | -5.08M | -- |
| Cash from Operations | 2.29M | -3.23M | 2.65M | 2.65M | -4.23M |
| Capital Expenditure | -- | -- | -753.30K | -753.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 217.60K | 217.60K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -383.80K | -210.50K | 422.90K | 422.90K | -137.90K |
| Cash from Investing | -383.80K | -210.50K | -112.90K | -112.90K | -137.90K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -72.00K | -72.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -2.00K | -2.00K | 2.00K |
| Cash from Financing | -- | -- | -10.30K | -10.30K | 300.00 |
| Foreign Exchange rate Adjustments | -236.40K | 41.50K | 797.80K | 797.80K | -494.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.67M | -3.40M | 3.32M | 3.32M | -4.86M |